<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Evento

Lipid profile and HDL-associated paroxonase in children with celiac disease. Impact of gluten free diet

Tetzlaff, Walter Francisco Icon; Bottero, Adriana ; Neder, Daniela ; Martin, Maximiliano Emanuel Icon; Botta, Eliana Elizabeth Icon; Ferraro, Maria Florencia Icon; Lozano Chiappe, Ezequiel Silvano Icon; Brites, Fernando Daniel Icon; Boero, Laura Estela

Otros responsables

Fecha

2020

Editorial

Fundación Revista Medicina

Revista

TĆ­tulo del libro

Nombre del evento

LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimenta; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas; VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio

Fecha del evento

2019-11-13

Institución organizadora

Sociedad Argentina de Investigación Clínica
Asociación Argentina de Farmacología Experimental
Sociedad Argentina de BiologĆ­a
Sociedad Argentina de ProtozoologĆ­a
Asociación Argentina de Nanomedicinas
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio

ISSN

1669-9106

eISSN

ISBN

Idioma

InglƩs

Tipo del evento

Reunión

Clasificación temÔtica

Resumen

There is growing evidence, both in adults and children, that celiac disease (CD) could be associated with non-identified atherogenic risk factors and, consequently, with cardiovascular disease. In this context, high density lipoproteins (HDL) constitute the only antiatherogenic fraction, being the inhibition of low density lipoprotein (LDL) oxidation one of its main functions. This capacity depends on several HDL-associated components, such as the antioxidant enzyme paraoxonase (PON1). Our objectives were: 1) To assess the relationship between CD and the presence of atherogenic risk factors in recently diagnosed children compared to healthy controls, and 2) the effect of gluten-free diet (GFD). The study included 22 CD children and 22 controls. Eleven CD children completed 6 months of GFD. Triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins A-I and B, glucose, haematological parameters, high sensitive C reactive protein (hsCRP), folic acid and vitamin B12 were measured by standardized methods. PON1 activity was evaluated employing two substrates: paraoxon (PON activity) and phenylacetate (ARE activity). There were significant differences in age between CD children and controls, so statistical analyses were performed adjusting by age. The CD children showed lower HDL-C, plasma iron, tranferrin saturation, folic acid and ARE activity (p<0.05) compared to controls. Regarding the longitudinal analysis, both HDL-C and PON1 activity increased while TG decreased after 6 months of GFD (p<0.05). Interestingly, after treatment HDL-C achieved by CD children resulted to be similar to the levels observed in control subjects. Conclusions: Children showed a more atherogenic lipid profile and lower ARE activity compared to healthy controls. These alterations were partially reversed after GFD, indicating a potentially beneficial effect of this treatment on both traditional risk factors and markers of HDL quality and functionality.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este Ć­tem se describe como by-nc-sa